BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND BCORL1, ENSG00000085185, 63035, FLJ11362, RP3-510O21_1, B930011H20Rik AND Prognosis
6234 results:

  • 1. Biomarkers for prognosis of meningioma patients: A systematic review and meta-analysis.
    Aung TM; Ngamjarus C; Proungvitaya T; Saengboonmee C; Proungvitaya S
    PLoS One; 2024; 19(5):e0303337. PubMed ID: 38758750
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A clinicopathological study of non-functioning pituitary neuroendocrine tumours using the World Health Organization 2022 classification.
    Woo CS; Ho RS; Ho G; Lau HT; Fong CH; Chang JY; Leung EK; Tang LC; Ma IK; Lee AC; Lui DT; Woo YC; Chow WS; Leung GK; Tan KC; Lam KS; Lee CH
    Front Endocrinol (Lausanne); 2024; 15():1368944. PubMed ID: 38756997
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Preoperative walking exercise to improve prognosis in patients with supratentorial brain tumours after craniotomy: protocol for a randomised controlled trial.
    Qu C; Cao Z; Zhou J; He S; Liu F; Liu Z
    BMJ Open; 2024 May; 14(5):e080787. PubMed ID: 38754891
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. EMP1 correlated with cancer progression and immune characteristics in pan-cancer and ovarian cancer.
    Zhang J; Yang J; Li X; Mao L; Zhang Y; Liu Y; Bao Y
    Mol Genet Genomics; 2024 May; 299(1):51. PubMed ID: 38743077
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Transcript and protein signatures derived from shared molecular interactions across cancers are associated with mortality.
    Zhao Y; Li X; Loscalzo J; Smelik M; Sysoev O; Wang Y; Mahmud AKMF; Mansour Aly D; Benson M
    J Transl Med; 2024 May; 22(1):444. PubMed ID: 38734658
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Glioma.
    Weller M; Wen PY; Chang SM; Dirven L; Lim M; Monje M; Reifenberger G
    Nat Rev Dis Primers; 2024 May; 10(1):33. PubMed ID: 38724526
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Altering biomolecular condensates as a potential mechanism that mediates cannabidiol effect on glioblastoma.
    Wang LP; Chagas PS; Salles ÉL; Naeini SE; Gouron J; Rogers HM; Khodadadi H; Bhandari B; Alptekin A; Qin X; Vaibhav K; Costigliola V; Hess DC; Dhandapani KM; Arbab AS; Rutkowski MJ; Yu JC; Baban B
    Med Oncol; 2024 May; 41(6):140. PubMed ID: 38713310
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. VEGFR2 blockade inhibits glioblastoma cell proliferation by enhancing mitochondrial biogenesis.
    Guo M; Zhang J; Han J; Hu Y; Ni H; Yuan J; Sun Y; Liu M; Gao L; Liao W; Ma C; Liu Y; Li S; Li N
    J Transl Med; 2024 May; 22(1):419. PubMed ID: 38702818
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prognostic Implications of Small Cell Lung cancer Transcriptional Subtyping for CNS Metastases.
    Tringale KR; Skakodub A; Egger J; Eichholz J; Yu Y; Gomez D; Rimner A; Li B; Yamada Y; Wilcox J; Moss N; Imber BS; Rekhtman N; Baine MK; Rudin CM; Pike LRG
    JCO Precis Oncol; 2024 Apr; 8():e2300470. PubMed ID: 38691815
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A novel immune cell signature for predicting glioblastoma after radiotherapy prognosis and guiding therapy.
    Huang R; Lu X; Sun X; Wu H
    Int J Immunopathol Pharmacol; 2024; 38():3946320241249395. PubMed ID: 38687369
    [No Abstract]    [Full Text] [Related]  

  • 11. Autophagy-related CMTM6 promotes glioblastoma progression by activating Wnt/β-catenin pathway and acts as an onco-immunological biomarker.
    Dai L; Xiao J; Li X; Tao Y; Zhou P; Lyu L; Shi Z; Liang X; Jia Z; Jiang S
    J Gene Med; 2024 May; 26(5):e3685. PubMed ID: 38686653
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Multi-cohort comprehensive analysis unveiling the clinical value and therapeutic effect of
    Liu Z; Yang L; Xie Z; Yu H; Gu T; Shi D; Cai N; Zhuo S
    Oncol Res; 2024; 32(5):965-981. PubMed ID: 38686055
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [SRSF2 promotes glioblastoma cell proliferation by inducing alternative splicing of FSP1 and inhibiting ferroptosis].
    Hua D; Zhou XX; Wang Q; Sun CY; Shi CJ; Luo WJ; Jiang ZD; Yu SZ
    Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):430-438. PubMed ID: 38678322
    [No Abstract]    [Full Text] [Related]  

  • 14. HIF-1α-mediated LAMC1 overexpression is an unfavorable predictor of prognosis for glioma patients: evidence from pan-cancer analysis and validation experiments.
    Bai J; Zhao Y; Shi K; Fan Y; Ha Y; Chen Y; Luo B; Lu Y; Jie W; Shen Z
    J Transl Med; 2024 Apr; 22(1):391. PubMed ID: 38678297
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. prognosis versus Actual Outcomes in Stereotactic Radiosurgery of brain Metastases: Reliability of Common Prognostic Parameters and Indices.
    Mangesius J; Seppi T; Arnold CR; Mangesius S; Kerschbaumer J; Demetz M; Minasch D; Vorbach SM; Sarcletti M; Lukas P; Nevinny-Stickel M; Ganswindt U
    Curr Oncol; 2024 Mar; 31(4):1739-1751. PubMed ID: 38668035
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Radiotherapy plus temozolomide with or without anlotinib in H3K27M-mutant diffuse midline glioma: A retrospective cohort study.
    Liu C; Kuang S; Huang T; Wu J; Zhang L; Gong X
    CNS Neurosci Ther; 2024 Apr; 30(4):e14730. PubMed ID: 38644565
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Radio-anatomical evaluation of clinical and radiomic profile of multi-parametric magnetic resonance imaging of de novo glioblastoma multiforme.
    Ahmed HS; Devaraj T; Singhvi M; Dasan TA; Ranganath P
    J Egypt Natl Canc Inst; 2024 Apr; 36(1):13. PubMed ID: 38644430
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Meningioma achieves malignancy and erastin-induced ferroptosis resistance through FOXM1-AURKA-NRF2 axis.
    Ye Y; Xu L; Zhang L; Zhao P; Cai W; Fu G; Wang T; Tao Z; Shi W; Gu W; Hu J; Yuan G; Wei Y; Xu K; Bao Z; Chao H; Liu N; Zhao L; Tu Y; Ji J
    Redox Biol; 2024 Jun; 72():103137. PubMed ID: 38642502
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Targeting the tumor microenvironment in primary central nervous system lymphoma: Implications for prognosis.
    Shi H; Sun X; Wu Y; Cui Q; Sun S; Ji N; Liu Y
    J Clin Neurosci; 2024 Jun; 124():36-46. PubMed ID: 38642434
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Identification and immunological characteristics of anoikis-associated molecular clusters in lung adenocarcinoma.
    He S; Xiao X; Ma C; Liu Y; Lin Q; Qian W; Cao C; Ren S; Chen J; Mi Y; Shen D
    Exp Cell Res; 2024 May; 438(1):114037. PubMed ID: 38631545
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 312.